- Home
- WAVE vs ALVR Comparison
WAVE vs ALVR Comparison
Compare WAVE & ALVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- ALVR
- Stock Information
- Founded
- WAVE 2011
- ALVR 2013
- Country
- WAVE Israel
- ALVR United States
- Employees
- WAVE N/A
- ALVR N/A
- Industry
- WAVE Electric Utilities: Central
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WAVE Utilities
- ALVR Health Care
- Exchange
- WAVE Nasdaq
- ALVR Nasdaq
- Market Cap
- WAVE 51.7M
- ALVR 48.8M
- IPO Year
- WAVE 2021
- ALVR 2020
- Fundamental
- Price
- WAVE $9.22
- ALVR $9.63
- Analyst Decision
- WAVE
- ALVR
- Analyst Count
- WAVE 0
- ALVR 0
- Target Price
- WAVE N/A
- ALVR N/A
- AVG Volume (30 Days)
- WAVE 32.2K
- ALVR 22.1K
- Earning Date
- WAVE 03-31-2025
- ALVR 03-14-2025
- Dividend Yield
- WAVE N/A
- ALVR N/A
- EPS Growth
- WAVE N/A
- ALVR N/A
- EPS
- WAVE N/A
- ALVR N/A
- Revenue
- WAVE $279,000.00
- ALVR N/A
- Revenue This Year
- WAVE N/A
- ALVR N/A
- Revenue Next Year
- WAVE N/A
- ALVR N/A
- P/E Ratio
- WAVE N/A
- ALVR N/A
- Revenue Growth
- WAVE 933.33
- ALVR N/A
- 52 Week Low
- WAVE $1.01
- ALVR $7.96
- 52 Week High
- WAVE $17.63
- ALVR $24.15
- Technical
- Relative Strength Index (RSI)
- WAVE 50.33
- ALVR 45.63
- Support Level
- WAVE $8.26
- ALVR $9.55
- Resistance Level
- WAVE $9.00
- ALVR $10.41
- Average True Range (ATR)
- WAVE 0.80
- ALVR 0.44
- MACD
- WAVE 0.17
- ALVR 0.05
- Stochastic Oscillator
- WAVE 64.62
- ALVR 22.77
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.